NewsRx

Search our medical news database

Neuropathy

ReBuilder Medical Technologies, Inc. Reports Huge 68% Increase in Neuropathy Sales

Published in Managed Care Law Weekly, October 18th, 2009

ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM) announced that as a result of their Medicare billing ability, September 2009 sales of their ReBuilder for neuropathy and arthritis are running 68% above August sales. Sales for September as of today are $315,979.

Doctors can now provide the ReBuilder Treatments to their neuropathy and arthritis patients, and the ReBuilder is covered by Medicare. The pain and numbness associated with neuropathy and arthritis can be effectively eliminated in just a few treatments. With many neuropathy patients having secondary insurance, most can expect to get their ReBuilders for free.

"We have just begun to...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook